| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 31.372 | 71.788 |
| Total Income - EUR | - | 0 | 0 | 31.439 | 0 | 0 | 293 | 1 | 31.383 | 43.221 |
| Total Expenses - EUR | - | 4.331 | 1.161 | 97.552 | 5.458 | 10.037 | 38.431 | 60.314 | 101.503 | 72.569 |
| Gross Profit/Loss - EUR | - | -4.331 | -1.161 | -66.112 | -5.458 | -10.037 | -38.137 | -60.313 | -70.120 | -29.348 |
| Net Profit/Loss - EUR | - | -4.331 | -1.161 | -67.056 | -5.458 | -10.037 | -38.141 | -60.313 | -70.120 | -29.348 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Onco Gyn Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 279.169 | 282.381 | 383.128 | 764.827 | 1.218.464 | 1.793.260 | 2.259.413 | 2.511.479 | 4.614.915 |
| Current Assets | - | 10.602 | 28.593 | 131.552 | 199.521 | 283.441 | 316.375 | 325.871 | 153.915 | 612.449 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 52.113 | 137 | 377 | 2.262 |
| Receivables | - | 5.966 | 23 | 57.189 | 157.438 | 226.254 | 141.703 | 195.499 | 98.562 | 593.888 |
| Cash | - | 4.636 | 28.570 | 74.363 | 42.083 | 57.187 | 122.559 | 130.235 | 54.976 | 16.299 |
| Shareholders Funds | - | -4.264 | -5.353 | -72.289 | -76.347 | -84.937 | -121.194 | -181.883 | -250.724 | -278.670 |
| Social Capital | - | 67 | 66 | 86 | 84 | 83 | 81 | 81 | 809 | 804 |
| Debts | - | 294.035 | 316.327 | 586.969 | 1.040.695 | 1.587.849 | 2.232.163 | 2.768.964 | 2.918.422 | 5.509.559 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6820 - 6820" | |||||||||
| CAEN Financial Year |
6820
|
|||||||||
Comments - Onco Gyn Srl